|POZEN To Present at NCINVEST2005 Investor Conference|
CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 7, 2005--POZEN Inc. (NASDAQ: POZN) announced today that John R. Plachetka, Pharm.D., the company's chairman, president and chief executive officer, will be speaking to investors at NCINVEST2005 on Wednesday, February 16, 2005 at 10:15 a.m. Eastern Time at the Friday Center in Chapel Hill, North Carolina. Dr. Plachetka's presentation will be webcast and archived on POZEN's home page at www.pozen.com.
POZEN is a pharmaceutical company committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has focused its efforts primarily on the development of pharmaceutical products for the treatment of migraine. POZEN is also exploring the development of product candidates in other pain-related therapeutic areas. POZEN has development and commercial alliances with GlaxoSmithKline, Xcel Pharmaceuticals, and Nycomed. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.
CONTACT: POZEN, Inc. Bill Hodges 919-913-1030 Chief Financial Officer or Fran Barsky 919-913-1044 Director, Investor Relations
SOURCE: POZEN, Inc.